8 Results for "

BLM helicases

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "BLM helicases" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-12342
CAS No.: 1430213-30-1
Purity:  99.89%
Synonyms: CID-49852229
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

ML216 (CID-49852229) is a potent, selective and cell permeable inhibitor of the DNA unwinding activity of BLM helicase with IC50s of 2.98 μM and 0.97 μM for BLM full-length and BLM 636-1298, respectively. ML216 inhibits ssDNA-dependent ATPase activity of BLM with a Ki of 1.76 μM. Antitumor avtivity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-110185
CAS No.: 203115-63-3
Purity:  99.18%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NSC 617145 is a selective werner syndrome helicase (WRN) helicase inhibitor with an IC50 value of 230 nM. NSC 617145 inhibits WRN ATPase, and induces double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 shows selective for WRN over BLM, FANCJ, ChlR1, RecQ, and UvrD helicases .
loading...
    loading...
Cat. No.: HY-128712
CAS No.: 714240-31-0
Purity:  98.88%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NCGC00029283 is a werner syndrome helicase-nuclease (WRN) helicase inhibitor with IC50s of 2.3 μM, 12.5 μM, and 3.4 μM for WRN, BLM and FANCJ helicase, respectively .
loading...
    loading...
Cat. No.: HY-178991
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-21 (Compound 11b) is a WRN helicase inhibitor with pIC50 values for WRN and BLM helicases of 3.6 and 5.4 respectively. WRN-IN-21 can be used for the study of MSI-related cancers .
loading...
    loading...
Cat. No.: HY-182634
CAS No.: 714932-54-4
Research Areas:  

Cancer

NCGC00063279 is a reversible Werner Syndrome Helicase-Nuclease (WRN) helicase inhibitor with modest selectivity over BLM and FANCJ helicases, and does not inhibit WRN exonuclease activity at active concentrations. NCGC00063279 inhibits Hematopoietic Protein Tyrosine Phosphatase (HePTP) and reduces proliferation of cancer cells. NCGC00063279 can be used for the research of osteosarcoma .
loading...
    loading...
Cat. No.: HY-110185R
CAS No.: 203115-63-3
Research Areas:  

Cancer

NSC 617145 (Standard) is the analytical standard of NSC 617145 (HY-110185). This product is intended for research and analytical applications. NSC 617145 is a selective werner syndrome helicase (WRN) helicase inhibitor with an IC50 value of 230 nM. NSC 617145 inhibits WRN ATPase, and induces double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 shows selective for WRN over BLM, FANCJ, ChlR1, RecQ, and UvrD helicases .
loading...
    loading...
Cat. No.: HY-181850
CAS No.: 3094716-52-3
Telomeric G4s ligand 2 is an orally active, selective ligand of telomeric G-quadruplex (G4), with an IC50 of 0.4 μM. Telomeric G4s ligand 2 binds to dimeric telomeric G4, inhibits the activities of DHX36 and BLM helicases. Telomeric G4s ligand 2 activates cGAS-STING and TERRA-ZBP1 pathways, inducing autophagy and G2/M cell cycle arrest, and exhibits antiproliferative effects across cancer cell lines. Telomeric G4s ligand 2 can be used for the study of colorectal cancer .
loading...
    loading...
Cat. No.: HY-183610
CAS No.: 3059172-54-9
Target:  

DNA/RNA Synthesis PAK

Research Areas:  

Cancer

WRN-IN-26 is an orally active Werner syndrome helicase (WRN) inhibitor with a human Ki value of 58.7 μM and an IC50 value of 0.026 μM. WRN-IN-26 selectively targets the cysteine residues of WRN. WRN-IN-26 induces the expression of p21 protein in MSI-H tumor cells. WRN-IN-26 inhibits the growth of MSI-H tumor cells and exhibits potent in vivo efficacy in MSI-H xenograft tumor models. WRN-IN-26 can be used for the research of microsatellite instability-high (MSI-H) cancers .
loading...
    loading...